Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

May 30, 2024

Study Completion Date

June 30, 2024

Conditions
Mental Health Therapists
Interventions
DRUG

Oxytocin nasal spray

Intranasal OT will be performed using a spray containing 24IU (12IU administered to each nostril), sorbitol, benzyl, alcohol glycerol, distilled water. Dosage and administration method was determined by standard OT studies instructions and guidelines. The substance will be prepared immediately after randomization by an external preparation and delivered and stored until administration under required conditions. The nasal spray will be self administered, with nursing staff supervising for proper administration of substance, and for supervision of side effects.

Trial Locations (1)

Unknown

Mental Health Clinic, Teradion, Misgav Regional Council

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Clalit Health Services

OTHER

lead

Shalvata Mental Health Center

OTHER

NCT06332066 - Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness | Biotech Hunter | Biotech Hunter